Chromatography-Based Cannabis Market Size, Share, Trends, Growth and Forecast 2032

Chromatography-Based Cannabis Industry Prospective:

The global chromatography-based cannabis market size was evaluated at $2500 million in 2023 and is slated to hit $11,500 million by the end of 2032 with a CAGR of nearly 18.48% between 2024 and 2032.

Request Free Sample

Chromatography-Based Cannabis Market: Overview

Cannabis is a complex natural product that comprises fatty acids, cannabinoids, sugar, terpenoids, hydrocarbons, and more. Moreover, chromatography is the process of separating as well as purifying the chemical compounds that are used at the time of cannabis testing. Cannabis testing is done to check the quality and efficiency of the cannabis so that it can be used for medical purposes and chromatography-based cannabis is used for the same.

Key Insights

• As per the analysis shared by our research analyst, the global chromatography-based cannabis market is projected to expand annually at the annual growth rate of around 18.48% over the forecast timespan (2024-2032)
• In terms of revenue, the global chromatography-based cannabis market size was evaluated at nearly $2500 million in 2023 and is expected to reach $11,500 millionby 2032.
• The global chromatography-based cannabis market is anticipated to grow rapidly over the forecast timeline owing to a prominent increase in research activities along with a rise in the use of cannabis for medicinal purposes.
• In terms of type, the liquid chromatography segment is slated to register the fastest CAGR over the forecast period.
• Based on application, the pain management segment is projected to lead the segmental expansion in the forecast timeframe.
• Region-wise, the European chromatography-based cannabis industry is projected to register the highest gains over the forecast timeframe.

Request Free Sample

Chromatography-Based Cannabis Market: Growth Factors

A surge in the research on cannabis use globally can boost the global market surge by 2032

The surging legalization of medical cannabis along with the rise in the cannabis testing labs across the globe is anticipated to pave the way for the growth of the global chromatography-based cannabis market. A prominent increase in research activities along with a rise in the use of cannabis for medicinal purposes is likely to embellish the progress of the market globally.

The technological advantage, government intervention, and fewer side effects are expected to surge the growth of the global market over the forecast timeframe. More than 20 states in the U.S. have legalized the use of cannabis for medical purposes which is expected to make this market across the globe grow at a substantial rate over the forecast years.

Chromatography-Based Cannabis Market: Restraints

Lack of standard protocols regarding cannabis testing can restrict the expansion of the global industry over the forecast period

Growing product costs can inhibit the expansion of the chromatography-based cannabis industry across the globe over the forecasting timeline. Non-uniformity of standard protocols related to the use of chromatography for cannabis testing purposes along with a ban on the use of cannabis in emerging economies can deter the expansion of the industry globally.

Chromatography-Based Cannabis Market: Opportunities

Surge in the demand for cannabis in the healthcare sector globally can open new growth avenues for the global market

The rise in the sale of cannabis for medical purposes across the globe is likely to open new avenues of growth for the global chromatography-based cannabis market. For instance, the first cannabis-based drug was approved by the U.S. government in June 2018 for epilepsy treatment. GW Pharmaceuticals PLC was the company that introduced this cannabis-based drug. Apart from this, escalating demand for medical cannabis is likely to steer the global market expansion by 2032.

Chromatography-Based Cannabis Market: Challenges

A rise in the prices of analytic devices can put a huge challenge for the global industry expansion over assessment period

A surge in the analytical instruments costs and the unavailability of trained lab experts are some of the key factors that can downsize the global chromatography-based cannabis industry expansion over the years ahead. An increase in the costs of testing cannabis in labs and a lack of industry standards for cannabis testing can challenge the expansion of the industry globally over the forecast period.

Chromatography-Based Cannabis Market: Segmentation

The global chromatography-based cannabis market is sectored into type, application, and region.                                    

In terms of type, the chromatography-based cannabis market across the globe is segregated into liquid chromatography and gas chromatography segments. Furthermore, the liquid chromatography segment, which garnered nearly 63% of the global market earnings in 2023, is anticipated to record the fastest CAGR during the period from 2024 to 2032. Moreover, the segmental surge in the coming eight years can be ascribed to massive demand for measuring the quality of cannabis.

Based on the application, the global chromatography-based cannabis industry is divided into seizures, pain management, and sclerosis segments. Moreover, the pain management segment, which led the application segment in 2023, is anticipated to dominate the segmental expansion in the coming eight years. The growth of the segment in the ensuing years can be due to an increase in the demand for chromatography-based cannabis procedures for testing cannabis before its use in pain management activities.

Chromatography-Based Cannabis Market: Report Scope

Chromatography-Based Cannabis Market: Regional Insights

North America is expected to dominate the global chromatography-based cannabis market surge over the period from 2024 to 2032

North America, which accounted for nearly 74% of the global chromatography-based cannabis market share in 2023, will be the leading region in the coming eight years. Moreover, the regional market elevation over the forecast timespan can be due to legalization as well as the use of cannabis for medical purposes. The presence of key players in countries such as Uruguay, the U.S., and Canada will proliferate the regional market size.

The European chromatography-based cannabis industry is anticipated to register the highest CAGR in the forecast timeframe. The surge of the industry in the continent in the coming decade can be due to a rise in the legalization of cannabis in countries such as Germany and the UK for its use for medicinal purposes.

Chromatography-Based Cannabis Market: Competitive Space

The global chromatography-based cannabis market profiles key players such as:

• CannaSafe
• Agilent Technologies Inc.
• Digipath Inc.
• Shimadzu Corporation
• EVIO Pvt. Ltd.
• LabLynx LIMS (Laboratory Information Management System)
• PerkinElmer Inc.
• Merck KGaA
• Pure Analytics LLC
• DH Tech. Dev. Pte. Ltd.
• Waters Corporation.
• PharmLabs LLC
• Restek Corporation.
• Accelerated Technology Laboratories Inc
• Steep Hill Inc.
• SC Labs.
• Digipath Inc.
• Battelle Memorial Institute
• PhytoVista Laboratories
• Eirlab Research Group
• CannaSafe

The global chromatography-based cannabis market is segmented as follows:

By Type

• Liquid Chromatography
•  Gas Chromatography

By Application

• Pain Management
• Seizures
• Sclerosis

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa